A Phase 2, open-label, single-arm, intra-subject dose-es

  • Lazaryan, Aleksandr (PI)

Project: Research project

Project Details

Description

A Phase 2, open-label, single-arm, intra-subject dose-escalation study to investigate the biological activity, safety, tolerability, and pharmacokinetics of ponesimod in subjects with symptomatic moderate or severe
StatusFinished
Effective start/end date5/1/154/30/19

Funding

  • Actelion Pharmaceuticals Ltd.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.